More on halo

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+48.1% Growth)
- Ratings (6.8 Score)
- Holders
- Event Driven Deals

Financials

Income Statement
Balance Sheet
Cash Flow Statement

Upcoming Events

- Earnings (11/3/26 *Est.)
- M&A (6/30/22 *Est)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Halozyme Therapeutics (NQ:HALO)
Delayed: 104.89 --0 (-0%)
Prev. Close $104.89  
Open$104.89 
52 Wk High$18.39 
52 Wk Low$6.96 
Day High$104.89 
Day Low$104.89 
P/E N/A  
EPS$-0.58 
Volume48 

Friends, Peers and Foes (?): ORKA, RBND, VRTX, MRUS, ABBV (more...)

Aug 18, 2026 04:04 PM Form 8-K HALOZYME THERAPEUTICS, For: Aug 14
Aug 18, 2026 04:01 PM Halozyme adds biotech executive Appelhans to its board
Aug 18, 2026 04:01 PM Halozyme Appoints Dannielle Appelhans to its Board of Directors
Aug 18, 2026 06:38 AM H.C. Wainwright Reiterates Buy Rating on Halozyme Therapeutics (HALO)
Aug 17, 2026 05:16 PM Form 144 HALOZYME THERAPEUTICS, Filed by: Torley Helen
Aug 11, 2026 05:58 PM Form 144 HALOZYME THERAPEUTICS, Filed by: Caudill Cortney
Aug 11, 2026 05:44 PM Form 4 HALOZYME THERAPEUTICS, For: Aug 10 Filed by: Connaughton Bernadette
Aug 10, 2026 04:34 PM Form 144 HALOZYME THERAPEUTICS, Filed by: Connaughton Bernadette
Aug 7, 2026 08:52 AM Halozyme Therapeutics (HALO) PT Raised to $105 at TD Cowen
Aug 7, 2026 08:19 AM Halozyme Therapeutics (HALO) PT Raised to $95 at Wells Fargo
View All Articles

Entities mentioned with halo

View All Entities